With a market cap of $166.5 billion, Danaher Corporation (DHR) is a global conglomerate specializing in designing, ...

On Friday, Danaher Corp (DHR) stock saw a decline, ending the day at $230.5 which represents a decrease of $-8.88 or -3.71% from the prior close of $239.38. The stock opened at $236.15 and touched a ...

Two dividend stocks are well-positioned for growth after adapting to challenges. Find out why CP and DHR offer solid returns ...

Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

Key market participants include Thermo Fisher Scientific, Agilent Technologies, Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories Inc., QIAGEN, GE Healthcare, Hoffmann-La Roche AG, and ...

Bearish flow noted in Danaher (DHR) with 1,213 puts trading, or 1.4x expected. Most active are Dec-24 250 calls and Dec-24 230 puts, with total ...

On Monday, Danaher Corp (DHR) stock saw a decline, ending the day at $247.18 which represents a decrease of $-0.58 or -0.23% from the prior close of $247.76. The stock opened at $248.78 and touched a ...

At this time, I would like to welcome everyone to the Danaher Corporation's Third Quarter 2024 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise.

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended September 27, 2024. All results in this release reflect only continuing operations unless otherwise noted.